Global and Regional Cytotoxic Drugs Market Details Research Report 2021-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Global Cytotoxic Drugs Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Cytotoxic Drugs market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Cytotoxic Drugs market.

    By Player:

    • Eli Lilly and Company

    • Lonza

    • Celgene Corp

    • Merck

    • Sanofi

    • Amgen

    • CytoPharma

    • Pfizer

    • Novartis

    • F Hoffmann-La Roche

    • Bristol-Myers Squibb

    • GlaxoSmithKline PLC

    • Johnson and Johnson

    • Teva Pharmaceutical

    By Type:

    • Alkylating Agents

    • Antitumor Antibiotics

    • Antimetabolites

    • Plant Alkaloids

    • Others

    By End-User:

    • Hospital

    • Cancer Research Center

    • Drug Testing Laboratory

    • CDMOs

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Cytotoxic Drugs Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Cytotoxic Drugs Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Cytotoxic Drugs Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Cytotoxic Drugs Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Cytotoxic Drugs Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Cytotoxic Drugs Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Eli Lilly and Company

      • 3.1.1 Eli Lilly and Company - Company Business Overview

      • 3.1.2 Eli Lilly and Company - Company Financial Performance

      • 3.1.3 Eli Lilly and Company - Company Financial Performance of Cytotoxic Drugs

      • 3.1.4 Cytotoxic Drugs Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Lonza

      • 3.2.1 Lonza - Company Business Overview

      • 3.2.2 Lonza - Company Financial Performance

      • 3.2.3 Lonza - Company Financial Performance of Cytotoxic Drugs

      • 3.2.4 Cytotoxic Drugs Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Celgene Corp

      • 3.3.1 Celgene Corp - Company Business Overview

      • 3.3.2 Celgene Corp - Company Financial Performance

      • 3.3.3 Celgene Corp - Company Financial Performance of Cytotoxic Drugs

      • 3.3.4 Cytotoxic Drugs Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Merck

      • 3.4.1 Merck - Company Business Overview

      • 3.4.2 Merck - Company Financial Performance

      • 3.4.3 Merck - Company Financial Performance of Cytotoxic Drugs

      • 3.4.4 Cytotoxic Drugs Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Sanofi

      • 3.5.1 Sanofi - Company Business Overview

      • 3.5.2 Sanofi - Company Financial Performance

      • 3.5.3 Sanofi - Company Financial Performance of Cytotoxic Drugs

      • 3.5.4 Cytotoxic Drugs Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Amgen

      • 3.6.1 Amgen - Company Business Overview

      • 3.6.2 Amgen - Company Financial Performance

      • 3.6.3 Amgen - Company Financial Performance of Cytotoxic Drugs

      • 3.6.4 Cytotoxic Drugs Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 CytoPharma

      • 3.7.1 CytoPharma - Company Business Overview

      • 3.7.2 CytoPharma - Company Financial Performance

      • 3.7.3 CytoPharma - Company Financial Performance of Cytotoxic Drugs

      • 3.7.4 Cytotoxic Drugs Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Pfizer

      • 3.8.1 Pfizer - Company Business Overview

      • 3.8.2 Pfizer - Company Financial Performance

      • 3.8.3 Pfizer - Company Financial Performance of Cytotoxic Drugs

      • 3.8.4 Cytotoxic Drugs Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Novartis

      • 3.9.1 Novartis - Company Business Overview

      • 3.9.2 Novartis - Company Financial Performance

      • 3.9.3 Novartis - Company Financial Performance of Cytotoxic Drugs

      • 3.9.4 Cytotoxic Drugs Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 F Hoffmann-La Roche

      • 3.10.1 F Hoffmann-La Roche - Company Business Overview

      • 3.10.2 F Hoffmann-La Roche - Company Financial Performance

      • 3.10.3 F Hoffmann-La Roche - Company Financial Performance of Cytotoxic Drugs

      • 3.10.4 Cytotoxic Drugs Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Bristol-Myers Squibb

      • 3.11.1 Bristol-Myers Squibb - Company Business Overview

      • 3.11.2 Bristol-Myers Squibb - Company Financial Performance

      • 3.11.3 Bristol-Myers Squibb - Company Financial Performance of Cytotoxic Drugs

      • 3.11.4 Cytotoxic Drugs Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 GlaxoSmithKline PLC

      • 3.12.1 GlaxoSmithKline PLC - Company Business Overview

      • 3.12.2 GlaxoSmithKline PLC - Company Financial Performance

      • 3.12.3 GlaxoSmithKline PLC - Company Financial Performance of Cytotoxic Drugs

      • 3.12.4 Cytotoxic Drugs Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Johnson and Johnson

      • 3.13.1 Johnson and Johnson - Company Business Overview

      • 3.13.2 Johnson and Johnson - Company Financial Performance

      • 3.13.3 Johnson and Johnson - Company Financial Performance of Cytotoxic Drugs

      • 3.13.4 Cytotoxic Drugs Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Teva Pharmaceutical

      • 3.14.1 Teva Pharmaceutical - Company Business Overview

      • 3.14.2 Teva Pharmaceutical - Company Financial Performance

      • 3.14.3 Teva Pharmaceutical - Company Financial Performance of Cytotoxic Drugs

      • 3.14.4 Cytotoxic Drugs Product Benchmarking

      • 3.14.5 Strategic Initiatives

    4 Global Cytotoxic Drugs Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Cytotoxic Drugs Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Alkylating Agents 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Antitumor Antibiotics 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Antimetabolites 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Plant Alkaloids 2016-2021

      • 4.2.5 Global Revenue and Growth Rate of Others 2016-2021

    • 4.3 Global Cytotoxic Drugs Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Alkylating Agents 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Antitumor Antibiotics 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Antimetabolites 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Plant Alkaloids 2016-2021

      • 4.3.5 Global Sales and Growth Rate of Others 2016-2021

    • 4.4 Global Cytotoxic Drugs Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Cytotoxic Drugs Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Cytotoxic Drugs Market Price By Type from 2016 to 2026

    5 Global Cytotoxic Drugs Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Cytotoxic Drugs

    • 5.2 Global Cytotoxic Drugs Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Hospital 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Cancer Research Center 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Drug Testing Laboratory 2016-2021

      • 5.2.4 Global Revenue and Growth Rate of CDMOs 2016-2021

    • 5.3 Global Cytotoxic Drugs Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Hospital 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Cancer Research Center 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Drug Testing Laboratory 2016-2021

      • 5.3.4 Global Sales and Growth Rate of CDMOs 2016-2021

    • 5.4 Global Cytotoxic Drugs Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Cytotoxic Drugs Market Sales and Market Share by Application (Forecast)

    6 Global Cytotoxic Drugs Market Segment Analysis (Geography Level)

    • 6.1 Global Cytotoxic Drugs Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Cytotoxic Drugs Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Cytotoxic Drugs Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Cytotoxic Drugs Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Cytotoxic Drugs Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Cytotoxic Drugs Market from 2016 to 2020

    7. North America Cytotoxic Drugs Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Cytotoxic Drugs Market Segment by Countries

      • 7.1.1 North America Cytotoxic Drugs Market Revenue Segment by Countries

      • 7.1.2 North America Cytotoxic Drugs Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Cytotoxic Drugs Market Segment (Product Type Level)

    • 7.3 North America Cytotoxic Drugs Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Cytotoxic Drugs Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Cytotoxic Drugs Market Segment by Countries

      • 8.1.1 Europe Cytotoxic Drugs Market Revenue Segment by Countries

      • 8.1.2 Europe Cytotoxic Drugs Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Cytotoxic Drugs Market Segment (Product Type Level)

    • 8.3 Europe Cytotoxic Drugs Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Cytotoxic Drugs Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Cytotoxic Drugs Market Segment by Countries

      • 9.1.1 Asia Cytotoxic Drugs Market Revenue Segment by Countries

      • 9.1.2 Asia Cytotoxic Drugs Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Cytotoxic Drugs Market Segment (Product Type Level)

    • 9.3 Asia Cytotoxic Drugs Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Cytotoxic Drugs Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Cytotoxic Drugs Market Segment by Countries

      • 10.1.1 South America Cytotoxic Drugs Market Revenue Segment by Countries

      • 10.1.2 South America Cytotoxic Drugs Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Cytotoxic Drugs Market Segment (Product Type Level)

    • 10.3 South America Cytotoxic Drugs Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Cytotoxic Drugs Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Cytotoxic Drugs Market Segment by Countries

      • 11.1.1 Middle East Cytotoxic Drugs Market Revenue Segment by Countries

      • 11.1.2 Middle East Cytotoxic Drugs Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Cytotoxic Drugs Market Segment (Product Type Level)

    • 11.3 Middle East Cytotoxic Drugs Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Cytotoxic Drugs Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Cytotoxic Drugs Market Segment by Countries

      • 12.1.1 Africa Cytotoxic Drugs Market Revenue Segment by Countries

      • 12.1.2 Africa Cytotoxic Drugs Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Cytotoxic Drugs Market Segment (Product Type Level)

    • 12.3 Africa Cytotoxic Drugs Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Cytotoxic Drugs Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Cytotoxic Drugs Market Segment by Countries

      • 13.1.1 Oceania Cytotoxic Drugs Market Revenue Segment by Countries

      • 13.1.2 Oceania Cytotoxic Drugs Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Cytotoxic Drugs Market Segment (Product Type Level)

    • 13.3 Oceania Cytotoxic Drugs Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Cytotoxic Drugs Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Cytotoxic Drugs

      • 14.2.2 Manufacturing Process Analysis of Cytotoxic Drugs

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Cytotoxic Drugs Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Cytotoxic Drugs Industry Market Status, Pre-COVID-19

      • 15.5.3 Cytotoxic Drugs Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Cytotoxic Drugs Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Cytotoxic Drugs Product Picture

    • Table Cytotoxic Drugs Product Definition

    • Table Study Scope by Types

    • Figure Global Cytotoxic Drugs Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Cytotoxic Drugs Market Value by Application (2016 - 2026)

    • Figure Global Cytotoxic Drugs Market Size and Growth Rate from 2016 to 2026

    • Table Global Cytotoxic Drugs Production Capacity by Manufacturers (2016-2021)

    • Table Global Cytotoxic Drugs Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Cytotoxic Drugs Revenue by Manufacturers (2016-2021)

    • Table Global Cytotoxic Drugs Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Cytotoxic Drugs Plant Distribution and Sales Country

    • Table Eli Lilly and Company - Company Business Overview

    • Figure Eli Lilly and Company Total Revenue from 2018 to 2020

    • Table Eli Lilly and Company Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eli Lilly and Company Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Lonza - Company Business Overview

    • Figure Lonza Total Revenue from 2018 to 2020

    • Table Lonza Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Lonza Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Celgene Corp - Company Business Overview

    • Figure Celgene Corp Total Revenue from 2018 to 2020

    • Table Celgene Corp Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Celgene Corp Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Celgene Corp

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Merck - Company Business Overview

    • Figure Merck Total Revenue from 2018 to 2020

    • Table Merck Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Merck Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Merck

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Sanofi - Company Business Overview

    • Figure Sanofi Total Revenue from 2018 to 2020

    • Table Sanofi Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sanofi Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Amgen - Company Business Overview

    • Figure Amgen Total Revenue from 2018 to 2020

    • Table Amgen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Amgen Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Cytotoxic Drugs Product Benchmarking

    • Table CytoPharma - Company Business Overview

    • Figure CytoPharma Total Revenue from 2018 to 2020

    • Table CytoPharma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure CytoPharma Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of CytoPharma

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Pfizer - Company Business Overview

    • Figure Pfizer Total Revenue from 2018 to 2020

    • Table Pfizer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pfizer Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Novartis - Company Business Overview

    • Figure Novartis Total Revenue from 2018 to 2020

    • Table Novartis Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novartis Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Cytotoxic Drugs Product Benchmarking

    • Table F Hoffmann-La Roche - Company Business Overview

    • Figure F Hoffmann-La Roche Total Revenue from 2018 to 2020

    • Table F Hoffmann-La Roche Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure F Hoffmann-La Roche Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Bristol-Myers Squibb - Company Business Overview

    • Figure Bristol-Myers Squibb Total Revenue from 2018 to 2020

    • Table Bristol-Myers Squibb Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bristol-Myers Squibb Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Cytotoxic Drugs Product Benchmarking

    • Table GlaxoSmithKline PLC - Company Business Overview

    • Figure GlaxoSmithKline PLC Total Revenue from 2018 to 2020

    • Table GlaxoSmithKline PLC Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GlaxoSmithKline PLC Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline PLC

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Johnson and Johnson - Company Business Overview

    • Figure Johnson and Johnson Total Revenue from 2018 to 2020

    • Table Johnson and Johnson Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Johnson and Johnson Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Johnson and Johnson

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Teva Pharmaceutical - Company Business Overview

    • Figure Teva Pharmaceutical Total Revenue from 2018 to 2020

    • Table Teva Pharmaceutical Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Teva Pharmaceutical Sales and Growth Rate Analysis of Cytotoxic Drugs

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical

    • Table Cytotoxic Drugs Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Cytotoxic Drugs Market Revenue by Types (Historical)

    • Table Global Cytotoxic Drugs Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Alkylating Agents 2016-2021

    • Figure Global Revenue and Growth Rate of Antitumor Antibiotics 2016-2021

    • Figure Global Revenue and Growth Rate of Antimetabolites 2016-2021

    • Figure Global Revenue and Growth Rate of Plant Alkaloids 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global Cytotoxic Drugs Market Sales by Types (Historical)

    • Table Global Cytotoxic Drugs Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Alkylating Agents 2016-2021

    • Figure Global Sales and Growth Rate of Antitumor Antibiotics 2016-2021

    • Figure Global Sales and Growth Rate of Antimetabolites 2016-2021

    • Figure Global Sales and Growth Rate of Plant Alkaloids 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global Cytotoxic Drugs Market Revenue by Types (Forecast)

    • Table Global Cytotoxic Drugs Market Revenue Market Share by Types (Forecast)

    • Table Global Cytotoxic Drugs Market Sales by Types (Forecast)

    • Table Global Cytotoxic Drugs Market Sales Market Share by Types (Forecast)

    • Figure Global Cytotoxic Drugs Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Cytotoxic Drugs

    • Table Global Cytotoxic Drugs Market Revenue by Application (Historical)

    • Table Global Cytotoxic Drugs Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Hospital 2016-2021

    • Figure Global Revenue and Growth Rate of Cancer Research Center 2016-2021

    • Figure Global Revenue and Growth Rate of Drug Testing Laboratory 2016-2021

    • Figure Global Revenue and Growth Rate of CDMOs 2016-2021

    • Table Global Cytotoxic Drugs Market Sales by Application (Historical)

    • Table Global Cytotoxic Drugs Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Hospital 2016-2021

    • Figure Global Sales and Growth Rate of Cancer Research Center 2016-2021

    • Figure Global Sales and Growth Rate of Drug Testing Laboratory 2016-2021

    • Figure Global Sales and Growth Rate of CDMOs 2016-2021

    • Table Global Cytotoxic Drugs Market Revenue by Application (Forecast)

    • Table Global Cytotoxic Drugs Market Revenue Market Share by Application (Forecast)

    • Table Global Cytotoxic Drugs Market Sales by Application (Forecast)

    • Table Global Cytotoxic Drugs Market Sales Market Share by Application (Forecast)

    • Table Global Cytotoxic Drugs Market Revenue by Geography (Historical)

    • Table Global Cytotoxic Drugs Market Revenue Market Share by Geography (Historical)

    • Figure Global Cytotoxic Drugs Revenue Market Share by Geography in 2020

    • Table Global Cytotoxic Drugs Market Sales by Geography (Historical)

    • Table Global Cytotoxic Drugs Market Sales Market Share by Geography (Historical)

    • Figure Global Cytotoxic Drugs Sales Market Share by Geography in 2020

    • Table Global Cytotoxic Drugs Market Revenue by Geography (Forecast)

    • Table Global Cytotoxic Drugs Market Revenue Market Share by Geography (Forecast)

    • Table Global Cytotoxic Drugs Market Sales by Geography (Forecast)

    • Table Global Cytotoxic Drugs Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Cytotoxic Drugs Revenue by Countries from 2016 to 2026

    • Table North America Cytotoxic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Cytotoxic Drugs Revenue Market Share by Major Countries in 2020

    • Table North America Cytotoxic Drugs Sales by Countries from 2016 to 2026

    • Table North America Cytotoxic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure North America Cytotoxic Drugs Sales Market Share by Major Countries in 2020

    • Figure USA Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure USA Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table North America Cytotoxic Drugs Sales by Types from 2016 to 2026

    • Table North America Cytotoxic Drugs Sales Market Share by Types from 2016 to 2026

    • Table North America Cytotoxic Drugs Value by Types from 2016 to 2026

    • Table North America Cytotoxic Drugs Value Market Share by Types from 2016 to 2026

    • Table North America Cytotoxic Drugs Sales by Application from 2016 to 2026

    • Table North America Cytotoxic Drugs Sales Market Share by Application from 2016 to 2026

    • Table North America Cytotoxic Drugs Value by Application from 2016 to 2026

    • Table North America Cytotoxic Drugs Value Market Share by Application from 2016 to 2026

    • Table Europe Cytotoxic Drugs Revenue by Countries from 2016 to 2026

    • Table Europe Cytotoxic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Cytotoxic Drugs Revenue Market Share by Major Countries in 2020

    • Table Europe Cytotoxic Drugs Sales by Countries from 2016 to 2026

    • Table Europe Cytotoxic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Cytotoxic Drugs Sales Market Share by Major Countries in 2020

    • Figure Germany Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure France Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure France Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Cytotoxic Drugs Sales by Types from 2016 to 2026

    • Table Europe Cytotoxic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Europe Cytotoxic Drugs Value by Types from 2016 to 2026

    • Table Europe Cytotoxic Drugs Value Market Share by Types from 2016 to 2026

    • Table Europe Cytotoxic Drugs Sales by Application from 2016 to 2026

    • Table Europe Cytotoxic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Europe Cytotoxic Drugs Value by Application from 2016 to 2026

    • Table Europe Cytotoxic Drugs Value Market Share by Application from 2016 to 2026

    • Table Asia Cytotoxic Drugs Revenue by Countries from 2016 to 2026

    • Table Asia Cytotoxic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Cytotoxic Drugs Revenue Market Share by Major Countries in 2020

    • Table Asia Cytotoxic Drugs Sales by Countries from 2016 to 2026

    • Table Asia Cytotoxic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Cytotoxic Drugs Sales Market Share by Major Countries in 2020

    • Figure China Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure China Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure India Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure India Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Cytotoxic Drugs Sales by Types from 2016 to 2026

    • Table Asia Cytotoxic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Asia Cytotoxic Drugs Value by Types from 2016 to 2026

    • Table Asia Cytotoxic Drugs Value Market Share by Types from 2016 to 2026

    • Table Asia Cytotoxic Drugs Sales by Application from 2016 to 2026

    • Table Asia Cytotoxic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Asia Cytotoxic Drugs Value by Application from 2016 to 2026

    • Table Asia Cytotoxic Drugs Value Market Share by Application from 2016 to 2026

    • Table South America Cytotoxic Drugs Revenue by Countries from 2016 to 2026

    • Table South America Cytotoxic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Cytotoxic Drugs Revenue Market Share by Major Countries in 2020

    • Table South America Cytotoxic Drugs Sales by Countries from 2016 to 2026

    • Table South America Cytotoxic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure South America Cytotoxic Drugs Sales Market Share by Major Countries in 2020

    • Figure Brazil Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table South America Cytotoxic Drugs Sales by Types from 2016 to 2026

    • Table South America Cytotoxic Drugs Sales Market Share by Types from 2016 to 2026

    • Table South America Cytotoxic Drugs Value by Types from 2016 to 2026

    • Table South America Cytotoxic Drugs Value Market Share by Types from 2016 to 2026

    • Table South America Cytotoxic Drugs Sales by Application from 2016 to 2026

    • Table South America Cytotoxic Drugs Sales Market Share by Application from 2016 to 2026

    • Table South America Cytotoxic Drugs Value by Application from 2016 to 2026

    • Table South America Cytotoxic Drugs Value Market Share by Application from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Revenue by Countries from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Cytotoxic Drugs Revenue Market Share by Major Countries in 2020

    • Table Middle East Cytotoxic Drugs Sales by Countries from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Cytotoxic Drugs Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Sales by Types from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Value by Types from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Value Market Share by Types from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Sales by Application from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Value by Application from 2016 to 2026

    • Table Middle East Cytotoxic Drugs Value Market Share by Application from 2016 to 2026

    • Table Africa Cytotoxic Drugs Revenue by Countries from 2016 to 2026

    • Table Africa Cytotoxic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Cytotoxic Drugs Revenue Market Share by Major Countries in 2020

    • Table Africa Cytotoxic Drugs Sales by Countries from 2016 to 2026

    • Table Africa Cytotoxic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Africa Cytotoxic Drugs Sales Market Share by Major Countries in 2020

    • Figure Nigeria Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Cytotoxic Drugs Sales by Types from 2016 to 2026

    • Table Africa Cytotoxic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Africa Cytotoxic Drugs Value by Types from 2016 to 2026

    • Table Africa Cytotoxic Drugs Value Market Share by Types from 2016 to 2026

    • Table Africa Cytotoxic Drugs Sales by Application from 2016 to 2026

    • Table Africa Cytotoxic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Africa Cytotoxic Drugs Value by Application from 2016 to 2026

    • Table Africa Cytotoxic Drugs Value Market Share by Application from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Revenue by Countries from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Cytotoxic Drugs Revenue Market Share by Major Countries in 2020

    • Table Oceania Cytotoxic Drugs Sales by Countries from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Cytotoxic Drugs Sales Market Share by Major Countries in 2020

    • Figure Australia Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Cytotoxic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Sales by Types from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Value by Types from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Value Market Share by Types from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Sales by Application from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Value by Application from 2016 to 2026

    • Table Oceania Cytotoxic Drugs Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Cytotoxic Drugs

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Cytotoxic Drugs with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.